These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19683256)

  • 1. Gastric acid inhibition for fat malabsorption or gastroesophageal reflux disease in cystic fibrosis: longitudinal effect on bacterial colonization and pulmonary function.
    van der Doef HP; Arets HG; Froeling SP; Westers P; Houwen RH
    J Pediatr; 2009 Nov; 155(5):629-33. PubMed ID: 19683256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis.
    Ratjen F; Comes G; Paul K; Posselt HG; Wagner TO; Harms K;
    Pediatr Pulmonol; 2001 Jan; 31(1):13-6. PubMed ID: 11180669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.
    Kerem E; Corey M; Gold R; Levison H
    J Pediatr; 1990 May; 116(5):714-9. PubMed ID: 2109790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
    Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
    Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease.
    Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
    Korean J Gastroenterol; 2016 Jul; 68(1):10-5. PubMed ID: 27443618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved pulmonary and growth outcomes in cystic fibrosis by newborn screening.
    Collins MS; Abbott MA; Wakefield DB; Lapin CD; Drapeau G; Hopfer SM; Greenstein RM; Cloutier MM
    Pediatr Pulmonol; 2008 Jul; 43(7):648-55. PubMed ID: 18500732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.
    Levy H; Kalish LA; Cannon CL; García KC; Gerard C; Goldmann D; Pier GB; Weiss ST; Colin AA
    Pediatr Pulmonol; 2008 May; 43(5):463-71. PubMed ID: 18361452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection, inflammation, and lung function decline in infants with cystic fibrosis.
    Pillarisetti N; Williamson E; Linnane B; Skoric B; Robertson CF; Robinson P; Massie J; Hall GL; Sly P; Stick S; Ranganathan S;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):75-81. PubMed ID: 21493738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.
    Kosorok MR; Zeng L; West SE; Rock MJ; Splaingard ML; Laxova A; Green CG; Collins J; Farrell PM
    Pediatr Pulmonol; 2001 Oct; 32(4):277-87. PubMed ID: 11568988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function.
    Winnie GB; Cowan RG
    Pediatr Pulmonol; 1991; 10(2):92-100. PubMed ID: 1903199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.
    Steinkamp G; Wiedemann B
    Thorax; 2002 Jul; 57(7):596-601. PubMed ID: 12096202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis.
    Palm K; Sawicki G; Rosen R
    Pediatr Pulmonol; 2012 Jun; 47(6):582-7. PubMed ID: 22162484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pancreatic status, CFTR mutations, Staphylococcus aureus and/or Pseudomonas aeruginosa infection/colonization on lung function in cystic fibrosis during a 2-year follow-up period.
    Pascoal MA; Marson FAL; Paschoal IA; Levy CE
    Wien Klin Wochenschr; 2020 Oct; 132(19-20):572-580. PubMed ID: 32356101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective and Objective Assessments of Flow-Volume Curve Configuration in Children and Young Adults.
    Weiner DJ; Forno E; Sullivan L; Weiner GA; Kurland G
    Ann Am Thorac Soc; 2016 Jul; 13(7):1089-95. PubMed ID: 27070374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
    Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
    Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients.
    Fugère A; Lalonde Séguin D; Mitchell G; Déziel E; Dekimpe V; Cantin AM; Frost E; Malouin F
    PLoS One; 2014; 9(1):e86705. PubMed ID: 24466207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
    Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P
    Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H
    Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.